Kedudukan dalam Saham
#3837
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Harga Saham
$99.89
Disegerakkan terakhir: 2026-08-25
Perdagangan BillionToOne, Inc. (BLLN)
Harga BLLN dengan permodalan pasaran b
Modal pasaran bagi BillionToOne, Inc.(BLLN)
Modal Pasaran: $4.59B
Sehingga August 2026, BillionToOne, Inc. mempunyai modal pasaran sebanyak $4.59B. Ini menjadikan BillionToOne, Inc. syarikat ke-3837th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran BillionToOne, Inc. dari 2025 hingga 2026
BLLN berbanding dengan 5 teratas yang paling popular stocks
| Harga BLLN |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.152T
|
+112,045.64%
|
|
|
|
|
$4.537T
|
+98,649.80%
|
|
|
|
|
$4.169T
|
+90,630.29%
|
|
|
|
|
$3.642T
|
+79,177.00%
|
|
|
|
|
$2.805T
|
+60,945.34%
|
